New Florida Vaccine Guidance Further Contradicts Federal Recommendations
"the State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines"
Building on its March 2022 Guidance regarding pediatric COVID-19 vaccines, Florida Health just released new guidance this October 7th, recommending against the mRNA vaccines for males under the age of 40.
“The Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally developed to evaluate vaccine safety.”
“This analysis found that there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination. With a high level of global immunity to COVID-19, the benefit of vaccination is likely outweighed by this abnormally high risk of cardiac-related death among men in this age group. Non-mRNA vaccines were not found to have these increased risks.”
The increase in the relative incidence of cardiac-related deaths got substantial attention on Twitter:


More specifically, one reads in the analysis document:
“In this statewide study of vaccinated Florida residents aged 18 years or older, COVID-vaccination was not associated with an elevated risk for all-cause mortality. COVID-19 vaccination was associated with a modestly increased risk for cardiac-related mortality 28 days following vaccination. Results from the stratified analysis for cardiac-related death following vaccination suggests mRNA vaccination may be driving the increased risk in males, especially among males aged 18 - 39. Risk for both all-cause and cardiac-related deaths was substantially higher 28 days following COVID-19 infection. The risk associated with mRNA vaccination should be weighed against the risk associated with COVID-19 infection.”
The new guidance reads as follows: “the State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines.”
Note that, while this guidance clearly contradicts federal guidance, it appears to be incomplete, as not covering adult women, including young / child baring age women and pregnant women, for which risks are well documented.
The issue of adverse events remains incompletely addressed, as these are well known to be numerous and too often serious or deadly - something that the federal regulatory authorities are aware of since early 2021.
Let’s remember that another jurisdiction, Denmark, has recently taken a much bolder step. It now does not recommend the vaccinations for those, males or females, under the age of 50.
A study of recent data from the Canadian province of Ontario concluded there is actually no rationale to vaccinate people below the age of 60.
Despite its shortcomings, this move by Florida is obviously noteworthy.
Will other States follow Florida’s guidance?
See media release:
https://content.govdelivery.com/accounts/FLDOH/bulletins/3312697
The analysis can be found at:
The guidance document can be found at:
The March 8 2022 medial release regarding paediatric vaccines can be found at: